Skip to main content

International Journal of Phytomedicine and Phytotherapy

Table 2 Objective symptom severity at Visit 1 and Visit 2

From: Effectiveness and tolerability of Tonsilgon® N in the treatment of recurrent upper respiratory tract infections in children: a non-interventional study in Russia

  

findings [N]

visit 2

 

visit 1

none

mild

moderate

severe

very severe

missing

nasopharyngitis

hyperemic mucosa

none

1

1

     

mild

37

36

1

    

moderate

203

193

6

1

1

 

2

severe

97

85

10

1

  

1

very severe

1

1

     

missing

       

total

339

316

17

2

1

 

3

 

swollen tonsils

none

57

57

     

mild

100

98

1

   

1

moderate

132

128

2

1

  

1

severe

47

45

1

   

1

very severe

3

3

     

missing

       

total

339

331

4

1

  

3

pharyngitis

hyperemic mucosa

none

       

mild

8

7

1

    

moderate

76

68

6

1

1

  

severe

62

57

5

    

very severe

5

5

     

missing

       

total

151

137

12

1

1

  
 

swollen tonsils

none

18

18

     

mild

39

38

1

    

moderate

59

58

 

1

   

severe

31

31

     

very severe

4

4

     

missing

       

total

151

149

1

1

   

tonsillitis

hyperemic mucosa

none

       

mild

12

11

1

    

moderate

67

59

6

1

1

  

severe

25

19

6

    

very severe

2

2

     

missing

       

total

106

91

13

1

1

  

swollen tonsils

none

1

1

     

mild

36

35

1

    

moderate

53

51

1

1

   

severe

15

15

     

very severe

1

1

     

missing

       

total

106

103

2

1